Loading clinical trials...
Loading clinical trials...
Observational Clinical Study of the Intravenous Blood Glucose System in Hospitalized Adult Elective or Non-Emergent Surgery and Medical/Surgical Intensive Care Unit Patients
The primary objective of this study is to evaluate the performance and safety of the intravenous blood glucose (IVBG) System relative to point of care (POC) meter performance when each method is compared to the Yellow Springs Instrument (YSI) under various conditions in the operating room (OR), ICU and general ward (GW) in subjects undergoing elective or non-emergent surgery as well as subjects admitted to the medical/surgical ICU. POC meter systems are currently used in the hospital environment to measure blood glucose values. The YSI is an accepted reference standard for assessing POC meter accuracy. The secondary objective of this study is to evaluate the performance of the IVBG System as compared with the YSI under various conditions in the operating room (OR), intensive care unit (ICU) and general ward (GW) in subjects undergoing elective or non-emergent surgery as well as subjects admitted to the medical/surgical ICU.
Subjects will have their glucose values collected from the IVBG System and compared with paired plasma glucose measurements obtained using theYSI with comparative blood samples collected from a CVC, an arterial line or a peripheral vein. * Blood samples collected per time point: approximately 2ml for waste and1mL for glucose measurement. In the event that a closed blood drawing system is utilized, the waste would be reduced or eliminated. * The comparative blood samples will be drawn manually at a maximum frequency of once every four hours. * Sample draws not to exceed 23 per subject for the duration of the study. This includes 18 comparative blood samples and 5 calibration samples to be draw as needed (e.g. recalibration). Including the partial thromboplastin time (PTT) draws described in section 3.1.2, there would be approximately 100 mL or 6.8 tablespoons drawn per subject. In the case where a closed blood drawing system is used consistently, this would be approximately 50 mL or 3.4 tablespoons per subject. POC meter blood glucose measurements will be performed at the same time as the blood sample draws described above.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Washington Hospital Center (WHC)
Washington D.C., District of Columbia, United States
University of Maryland School of Medicine
Baltimore, Maryland, United States
International Diabetes Center (IDC), Methodist Hospital
Minneapolis, Minnesota, United States
Providence Heart and Vascular Institute
Portland, Oregon, United States
Thomas Jefferson University
Philadelphia, Pennsylvania, United States
Start Date
June 1, 2009
Primary Completion Date
April 1, 2010
Completion Date
May 1, 2010
Last Updated
August 20, 2013
100
ACTUAL participants
Intravenous Blood Glucose monitoring system
DEVICE
Lead Sponsor
Edwards Lifesciences
Collaborators
NCT07043478
NCT07256652
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06973408